Bankruptcy and Financial Distress Litigation

With one of the largest in-house teams of economists in the economic consulting world, NERA's Bankruptcy and Financial Distress Litigation Practice combines expertise in economics, finance, accounting, and valuation with specific industry knowledge. Our experts provide economic analysis of securities disputes and corporate governance, valuation of companies, portfolios including assets and derivatives, and professional compensation. In addition to employing standard valuation methods, NERA economists draw on advanced valuation techniques and econometric and statistical models, as needed.

We assist clients in disputes over:

  • Plan confirmation
  • Preference and fraudulent conveyance claims
  • Solvency and valuation disputes
  • Alleged breaches of fiduciary duty by directors and officers of distressed companies
  • Lender liability claims
  • The feasibility of alternative restructuring plans

We are also frequently retained by litigation counsel to provide expert testimony involving these and other claims in bankruptcy adversary proceedings. Our capabilities include:

  • Expert testimony on liability and damages
  • Solvency and capital adequacy analysis in fraudulent conveyance and bankruptcy
  • Valuation of assets, including enterprises and intangible assets
  • Valuation of derivatives and complex securities
  • Assessment of the reasonableness of certain assumptions used in valuation, using market indicators such as credit default swaps
  • Cash flow analysis of the effect of transfers on the solvency and capital adequacy of the debtor
  • Econometric modeling for assessing projections
  • Valuation, at the time of transfer, of long-tailed liabilities or other disputed claims

We have experience and specialized institutional knowledge in industries including energy, health care, oil and gas, construction, financial services, housing finance, and media and telecommunications. We also have expertise in finance, accounting, antitrust economics (analysis of competitive effects), structured finance, mass tort and liability valuation, analysis of ERISA plans, intellectual property valuation, and transfer pricing.

Clients benefit from the integration of the expertise of our many professional disciplines, our experience as consultants, testifying experts, and arbitrators, and our firm's exacting standards for rigor and objectivity.

Name Title Location Phone Email
Lucy P. Allen Senior Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Dr. Patrick Conroy Senior Managing Director Miami +1 305 341 5025 patrick.conroy@nera.com
Dr. Denise Neumann Martin Senior Managing Director Miami +1 305 808 7880 denise.martin@nera.com
Dr. Faten Sabry Senior Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Dr. Ramsey Shehadeh Senior Managing Director Washington, DC +1 212 345 6089 ramsey.shehadeh@nera.com
Dr. David Tabak Senior Managing Director New York City +1 212 345 2176 david.tabak@nera.com
Jorge Baez Managing Director Miami
New York City
Mexico City
+1 305 341 5060
+1 212 345 5753
+52 55 9628 7550
jorge.baez@nera.com
Dr. Charles Parekh Managing Director Chicago +1 312 573 4809 charles.parekh@nera.com
Dr. Stephanie Plancich Managing Director New York City +1 212 345 7719 stephanie.plancich@nera.com
Mary Elizabeth C. Stern Managing Director White Plains, NY +1 914 448 4054 mary.elizabeth.stern@nera.com
Dr. Airat Chanyshev Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Drew Claxton Director New York City +1 212 345 3442 drew.claxton@nera.com
Dr. Alan Grant Director Washington, DC +1 202 466 3510 alan.grant@nera.com
William P. Hrycay Director New York City +1 212 345 1518 william.hrycay@nera.com
Timothy McKenna Director Los Angeles
New York City
+1 213 346 3041
+1 212 345 3000
timothy.mckenna@nera.com
Ivelina Velikova Director New York City +1 212 345 1160 ivelina.velikova@nera.com
Mark L. Berenblut Affiliated Consultant Toronto
New York City
London
+1 416 868 7311
+1 917 475 0020
+44 20 3769 1096
mark.berenblut.affiliate@nera.com
Dr. Sharon Brown-Hruska Affiliated Consultant Washington, DC +1 202 466 3510 sharon.hruska.affiliate@nera.com
Mike King Affiliated Consultant Denver
San Francisco
Washington, DC
+1 303 357 4781
+1 303 618 4915
+1 303 618 4915
mike.king.affiliate@nera.com
Prof. Dr. David Nickerson Affiliated Academic Washington, DC +1 202 466 3510 david.nickerson.affiliate@nera.com
Dr. Michael Rosenzweig Affiliated Consultant Washington, DC +1 202 466 9231 michael.rosenzweig.affiliate@nera.com
Title Type Author
Trends in Canadian Securities Class Actions: 2022 Update Published Article Bradley Heys, Robert Patton, and Jielei Mao
What Happened to SVB? Not a 2008 Repeat Story White Paper Dr. Faten Sabry, William Hrycay, and Sungi Lee
Snapshot of Recent Trends in Asbestos Litigation: 2022 Update White Paper Mary Elizabeth Stern and Lucy Allen
How Will the LIBOR Transition Affect Mortgage Consumers? White Paper Dr. Faten Sabry and Ramisa Roya, et al.
Trends in Canadian Securities Class Actions: 2021 Update White Paper Bradley A. Heys, Robert Patton, Jielei Mao
Snapshot of Recent Trends in Asbestos Litigation 2021 Update Mary Elizabeth C. Stern and Lucy P. Allen
How COVID-19 Impact Analysis May Shape MAE Disputes Published Article Dr. David Tabak and Edward Flores
COVID-19, MAEs, and Preliminary Evidence of Disproportionate Impacts Within Industrie... Brief Dr. David Tabak and Edward Flores
S&P 500 Index: Daily Price Movements Brief Dr. David Tabak and Edward Flores
Manufactured Defaults and the Use of Credit Default Swaps Report Dr. Faten Sabry and David Cen, et al.